FI101795B1 - Förfaranden för framställning och isolering av form-II-diritromycin samt kristallin solvat av diritromycin, användbar som mellanprodukt - Google Patents

Förfaranden för framställning och isolering av form-II-diritromycin samt kristallin solvat av diritromycin, användbar som mellanprodukt

Info

Publication number
FI101795B1
FI101795B1 FI921877A FI921877A FI101795B1 FI 101795 B1 FI101795 B1 FI 101795B1 FI 921877 A FI921877 A FI 921877A FI 921877 A FI921877 A FI 921877A FI 101795 B1 FI101795 B1 FI 101795B1
Authority
FI
Finland
Prior art keywords
dirithromycin
solvate
isolation
useful
preparation
Prior art date
Application number
FI921877A
Other languages
English (en)
Finnish (fi)
Other versions
FI921877A (fi
FI921877A0 (fi
FI101795B (sv
Inventor
James Michael Greene
Holly Marie Hankins
Gregory Alan Stephenson
David Dale Wirth
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI921877A0 publication Critical patent/FI921877A0/fi
Publication of FI921877A publication Critical patent/FI921877A/fi
Application granted granted Critical
Publication of FI101795B1 publication Critical patent/FI101795B1/sv
Publication of FI101795B publication Critical patent/FI101795B/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Formation And Processing Of Food Products (AREA)
FI921877A 1991-04-29 1992-04-27 Förfaranden för framställning och isolering av form-II-diritromycin sa mt kristallin solvat av diritromycin, användbar som mellanprodukt FI101795B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69284291A 1991-04-29 1991-04-29
US69284291 1991-04-29

Publications (4)

Publication Number Publication Date
FI921877A0 FI921877A0 (fi) 1992-04-27
FI921877A FI921877A (fi) 1992-10-30
FI101795B1 true FI101795B1 (sv) 1998-08-31
FI101795B FI101795B (sv) 1998-08-31

Family

ID=24782254

Family Applications (2)

Application Number Title Priority Date Filing Date
FI921877A FI101795B (sv) 1991-04-29 1992-04-27 Förfaranden för framställning och isolering av form-II-diritromycin sa mt kristallin solvat av diritromycin, användbar som mellanprodukt
FI921876A FI921876A (fi) 1991-04-29 1992-04-27 Farmaceutisk komposition innehaollande diritromycin

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI921876A FI921876A (fi) 1991-04-29 1992-04-27 Farmaceutisk komposition innehaollande diritromycin

Country Status (27)

Country Link
EP (2) EP0511799B1 (sv)
JP (2) JP3135672B2 (sv)
KR (2) KR100193742B1 (sv)
CN (2) CN1030611C (sv)
AT (2) ATE138924T1 (sv)
AU (2) AU646734B2 (sv)
BR (2) BR9201540A (sv)
CA (2) CA2067275C (sv)
CY (2) CY1946A (sv)
CZ (2) CZ282021B6 (sv)
DE (2) DE69214710T2 (sv)
DK (2) DK0511800T3 (sv)
ES (2) ES2093779T3 (sv)
FI (2) FI101795B (sv)
GR (2) GR3020439T3 (sv)
HK (2) HK153696A (sv)
HU (2) HU213613B (sv)
IE (2) IE76296B1 (sv)
IL (2) IL101705A (sv)
MX (2) MX9201944A (sv)
MY (2) MY109498A (sv)
NO (2) NO179504C (sv)
NZ (2) NZ242506A (sv)
RU (2) RU2070203C1 (sv)
TW (2) TW315371B (sv)
YU (2) YU44392A (sv)
ZA (2) ZA922777B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW271400B (sv) * 1992-07-30 1996-03-01 Pfizer
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
DE29724846U1 (de) * 1996-07-29 2004-12-16 Abbott Laboratories, Abbott Park Herstellung von kristalliner Form II von Clarithromycin
TR199900651T2 (xx) * 1996-09-24 1999-07-21 Eli Lilly And Company Kaplanm�� par�ac�k form�lasyonu.
US6390690B1 (en) 2000-05-17 2002-05-21 3M Innovative Properties Company Fiber optic connector for coupling devices on intersecting planes
CN101547931B (zh) * 2006-12-05 2012-11-14 辉瑞有限公司 促动内酯多晶型
CN102145008B (zh) * 2010-12-29 2013-06-05 辰欣药业股份有限公司 一种地红霉素药物组合物及其制备方法
CN107151261B (zh) * 2017-06-09 2020-06-12 广州大光制药有限公司 一种地红霉素化合物的晶型及其结晶制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2515075C2 (de) * 1975-04-07 1985-10-24 Dr. Karl Thomae Gmbh, 7950 Biberach Erythromycinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
AT342770B (de) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K Verfahren zur herstellung neuer erythromycinderivate
EP0184921A3 (en) * 1984-12-08 1986-10-29 Beecham Group Plc Erythromycin derivatives
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
EP0511800B1 (en) 1996-10-23
DK0511799T3 (da) 1996-06-24
DE69211220T2 (de) 1996-11-07
KR100194307B1 (ko) 1999-06-15
HU9203168D0 (en) 1992-12-28
AU646734B2 (en) 1994-03-03
MY109498A (en) 1997-02-28
IE74885B1 (en) 1997-08-13
EP0511800A1 (en) 1992-11-04
HUT63956A (en) 1993-11-29
NO180450B (no) 1997-01-13
ZA922776B (en) 1993-10-15
MY114226A (en) 2002-09-30
NO179504C (no) 1996-10-23
ATE144425T1 (de) 1996-11-15
NO179504B (no) 1996-07-15
RU2045953C1 (ru) 1995-10-20
HUT62595A (en) 1993-05-28
CA2067275A1 (en) 1992-10-30
KR100193742B1 (ko) 1999-06-15
NZ242506A (en) 1993-09-27
CY1975A (en) 1997-09-05
FI921876A (fi) 1992-10-30
NO180450C (no) 1997-04-23
DE69214710T2 (de) 1997-03-13
JP3333545B2 (ja) 2002-10-15
CN1030611C (zh) 1996-01-03
NZ242505A (en) 1993-06-25
CS127792A3 (en) 1992-11-18
HK215096A (en) 1996-12-13
YU44392A (sh) 1994-12-28
ES2093779T3 (es) 1997-01-01
AU1525592A (en) 1992-11-05
EP0511799A1 (en) 1992-11-04
CA2067274C (en) 2002-10-15
DE69214710D1 (de) 1996-11-28
GR3020439T3 (en) 1996-10-31
DE69211220D1 (de) 1996-07-11
IE921346A1 (en) 1992-11-04
CN1066270A (zh) 1992-11-18
CZ282021B6 (cs) 1997-04-16
TW216399B (sv) 1993-11-21
DK0511800T3 (da) 1997-04-21
IL101705A (en) 1996-01-31
MX9201944A (es) 1992-11-01
IE921345A1 (en) 1992-11-04
HU9201398D0 (en) 1992-07-28
MX9201946A (es) 1992-11-01
CZ282218B6 (cs) 1997-06-11
HU213613B (en) 1997-08-28
KR920019364A (ko) 1992-11-19
CA2067274A1 (en) 1992-10-30
ATE138924T1 (de) 1996-06-15
BR9201540A (pt) 1992-12-01
CA2067275C (en) 2002-11-26
NO921617L (no) 1992-10-30
CN1069197C (zh) 2001-08-08
FI921877A (fi) 1992-10-30
IL101704A0 (en) 1992-12-30
TW315371B (sv) 1997-09-11
HU215917B (hu) 1999-03-29
IL101704A (en) 1998-02-22
CS127692A3 (en) 1992-11-18
JPH05117289A (ja) 1993-05-14
NO921616L (no) 1992-10-30
BR9201541A (pt) 1992-12-01
KR920019365A (ko) 1992-11-19
JP3135672B2 (ja) 2001-02-19
NO921617D0 (no) 1992-04-27
EP0511799B1 (en) 1996-06-05
ZA922777B (en) 1993-10-15
FI921876A0 (fi) 1992-04-27
CN1066186A (zh) 1992-11-18
IL101705A0 (en) 1992-12-30
CY1946A (en) 1992-04-27
HK153696A (en) 1996-08-16
YU44492A (sh) 1994-06-24
FI921877A0 (fi) 1992-04-27
AU655978B2 (en) 1995-01-19
IE76296B1 (en) 1997-10-08
JPH05117154A (ja) 1993-05-14
GR3021706T3 (en) 1997-02-28
NO921616D0 (no) 1992-04-27
ES2088098T3 (es) 1996-08-01
AU1525792A (en) 1992-11-05
RU2070203C1 (ru) 1996-12-10
FI101795B (sv) 1998-08-31

Similar Documents

Publication Publication Date Title
AU531146B2 (en) Piperidine derivatives
FI942345A (sv) Förfarande för framställning av prolinboronatester
IL59157A0 (en) Piperidine derivatives
DK0606248T3 (da) Heteroarylaminer som hidtil ukendte acetylcholinesteraseinhibitorer
IT1217284B (it) Dispositivo di regolazione per la sincronizzazione di alcuni azionamenti
IT1257275B (it) Combustore per pulsoreattore
FI940769A (sv) Förfarande för framställning av 2-aminotiazolderivat
DE69118072D1 (de) Piezoelektrischer Transformator
DE69127859T2 (de) Kartonzuführvorrichtung
NO920965D0 (no) Fremgangsmaate for fremstilling av etylen-alfa-olefinkopolymerer
FI101795B1 (sv) Förfaranden för framställning och isolering av form-II-diritromycin samt kristallin solvat av diritromycin, användbar som mellanprodukt
NO895195D0 (no) Fremgangsmaate for fremstilling av piperidinderivater samtmellomprodukter.
DE59007614D1 (de) Piezokeramischer Transformator.
FI923624A (fi) Dubbelt tillslutbart och avloppsventilsystem med foerbaettrad stroemningshanteringsegenskap
NO942218D0 (no) Fremgangsmåte for fremstilling av karbonatsammensetning
AU6020280A (en) Drill table height adjustment
FR2614392B1 (fr) Four crematoire perfectionne
FI923360A (fi) Foerfarande foer framstaellning av dimetylacetoacetamid
IT8947902A0 (it) Procedimento per preparare composti antibiotici
NO921538L (no) Fremgangsmaate for fremstilling av et glycidylazid-polymerazid
KR930009339U (ko) 프리크랙 발생용 복식지그
DK299184A (da) Vaekstinhibitor for cariogene bakterier
FI963354A0 (sv) Förfarande för framställning av piperidinderivat
ES2032573T3 (es) Procedimiento de preparacion de derivados de 4,4-dimetil-tetrahidropir-2-ona.
AU5759080A (en) Dihydropyridine derivatives